Penumbra (PEN) Tax Rate Growth (5y) (2019 - 2026)
Penumbra (PEN) Tax Rate Growth (5y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.51 Bn | 174.21 Bn | 6.27 Bn |
| 2 | Stryker | 128.52 Bn | 125.64 Bn | 3.81 Bn |
| 3 | Medtronic | 108.06 Bn | 98.84 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.04 Bn | 66.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.17 Bn | 1.98 Bn |
| 7 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.88 Bn | 26.30 Bn | - |
| 9 | Koninklijke Philips | 25.42 Bn | 22.29 Bn | 2.07 Bn |
| 10 | Penumbra | 12.54 Bn | 11.93 Bn | 253.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 947.00 |
| Dec 31, 2025 | -58,947.00 |
| Sep 30, 2025 | -3,757.00 |
| Mar 31, 2025 | -20,847.00 |
| Dec 31, 2024 | 320.00 |
| Sep 30, 2024 | 1,075.00 |
| Jun 30, 2024 | 4,293.00 |
| Mar 31, 2024 | 1,256.00 |
| Dec 31, 2023 | -5,413.00 |
| Sep 30, 2023 | 3,877.00 |
| Jun 30, 2023 | 5,428.00 |
| Mar 31, 2023 | 4,407.00 |
| Dec 31, 2022 | 19,676.00 |
| Sep 30, 2022 | 13,802.00 |
| Jun 30, 2022 | -16,343.00 |
| Mar 31, 2022 | 17,893.00 |
| Dec 31, 2021 | 9,800.00 |
| Sep 30, 2021 | -119,349.00 |
| Jun 30, 2021 | -86,802.00 |
| Mar 31, 2021 | 2,038.00 |